Principles of antimicrobial stewardship: the what and the how
13 - 17 June 2022
Nijmegen, the Netherlands
Organisers
Dutch Working Party on Antibiotic Policy (Dutch acronym is SWAB)
Module objectives
This module is intended as the basic course AMS for the new ESCMID AMS European certificate, covering in-depth the principles and practices of AMS. Participants will be prepared for research and academic positions, teaching roles in national and international AMS organisations, professions in Antimicrobial Stewardship Programmes for healthcare institutions, and government positions.
Target Audience
ID Physicians, Medical Microbiologists, Clinical Pharmac(olog)ists, ICU physicians, Internists, Specialist Nurses, Pediatricians and other medical specialties.
Module venue
Fletcher Hotel Erica
Molenbosweg 17
6571 BA Berg en Dal
The Netherlands
Accreditation
28 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Individual module registration fee
AMS Certificate trainee: Automatic registration
ESCMID member: 950 €
No ESCMID member: 1095 €
Preliminary programme
Day 1 | ||
MORNING PROGRAM Antimicrobial Stewardship Introduction / General principles of antimicrobial therapy | ||
09:00 – 09:15 | Welcome and introduction | Dr. Jeroen Schouten |
09:15 – 10:00 | BASIC requirements of an Antimicrobial stewardship Program, an interactive overview | Dr. Jaap ten Oever |
10:00 – 10:30 | BASIC requirements of an Antimicrobial stewardship Program, the role of Microbiology (diagnostic stewardship) | Prof. dr. Heiman Wertheim |
10:30 – 11:00 | The WHAT of antimicrobial stewardship (objectives) | Prof. dr. Jan Prins |
Break | ||
11:15 – 11:45 | Epidemiology of resistance. Current situation and trends in Europe. How do you weigh this? Where do you get the (local) data from? How does this affect outcomes? | Dr. Mark de Boer |
11:45 – 12:30 | Interdisciplinary consultations: a lesson in empathy / combining multiple perspectives | Prof. Dr. Bhanu Sinha |
AFTERNOON Workshop Implementation in practice (part I) “What is exactly my problem?” | ||
13:30 – 14:30 | The HOW of antimicrobial stewardship: how do I make sure that what is implemented/performed in daily practice | Prof. Dr. Marlies Hulscher |
14:30 – 15:00 | Presentation of a “My project” performed by a course Alumnus: “How did I approach my own Antimicrobial Stewardship problem and improve ? “ | |
15:00 – 16:30 | Workshop: introduction of all participants to their main AMS problem: group discussion to define one major problem per group. | |
16:30 – 18:00 | Social Event (Bike tour / Walk in the woods) | |
DAY 2 | ||
MORNING PROGRAM Optimizing Antimicrobial therapy | ||
09:00 – 09:45 | EUCAST methodology of breakpoints , clinical breakpoints, ECOFFs and susceptibility | Dr. Anouk Muller |
09:45 – 10:30 | Practical PK/PD: Leads for optimal dosing, also in situations of altered organ function | Dr. Paul van der Linden |
Break | ||
11:00 – 11:45 | Practical PK/PD: therapeutic drug monitoring (TDM) to optimize efficacy and prevent toxicity | Dr. Reinier van Hest |
11:45 – 12:30 | How to manage (suspected) antibiotic allergy and possibilities for stewardship | Dr. Mark de Boer |
AFTERNOON Workshop Implementation in practice (part IIa) “How do I measure the quantity of antimicrobial use?” | ||
13:30 – 14:00 | Quantity of antimicrobial use: the basics | Dr. Nynke Jager |
14:00 – 15:00 | Workshop “How to deduct Quantitative Measures | Dr. Paul van der Linden |
Break | ||
Workshop Implementation in practice (part IIb) “How do I measure the quality of antimicrobial use?” | ||
Break | ||
Workshop Implementation in practice (part IIb) “How do I measure the quality of antimicrobial use?” | ||
15:30 – 16:00 | Quality Indicators in Antimicrobial Stewardship, the basics | Prof. Dr. Marlies Hulscher |
16:00 – 17:00 | Workshop “How to operationalize Quality indicators for appropriate antimicrobial use” | |
17:00 – 17:30 | Performing a Point Prevalence Survey, the basics | Dr. Jaap ten Oever |
17:30 – 18:30 | Workshop “How to conduct a Point Prevalence Survey, interpret and present results” | |
Free evening | ||
DAY 3 | ||
MORNING PROGRAM Changing therapy: escalation and de-escalation / IV oral switch | ||
09:00 – 09:30 | Markers of inflammation and infection: how to interpret (e.g. CRP, PCT, leukocytes)? Can they be used to tailor treatment duration? | Dr. Mark de Boer |
09:30 – 10:00 | Rapid) microbiological diagnostics: how to interpret? | Prof. Dr. Bhanu Sinha |
10:00 – 10:30 | Benefits of early IV-oral switch: low hanging fruit in Antimicrobial Stewardship Programs | Prof. Dr. Jan Prins |
Break | ||
11:00 – 11:45 | Escalation and De-escalation practice: how to do this in daily practice? | Dr. Mark de Boer |
11:45 – 12:30 | Follow-up diagnostics in S. aureus bacteremia consultations | Dr. Kim Sigaloff |
14:00 – 22:00 | Social Event: Lunch on the go | |
DAY 4 | ||
MORNING PROGRAM Stopping therapy and discharge with therapy at home | ||
09:00 – 09:30 | Stopping antibiotics and duration of antibiotic therapy. Guidelines vs practice | Prof. Dr. Jan Prins |
09:30 – 10:00 | (Prolonged) Antibiotic prophylaxis in perioperative and medical settings | Dr. Mark de Boer |
10:00 – 10:30 | IV antimicrobial therapy at home: OPAT, drug options, controls and toxicity | Dr. Jaap ten Oever Dr. Rogier van Hest Dr. Paul van der Linden |
Workshop Implementation in practice (part III) “How do I analyse barriers?” | ||
11:00 – 11:30 | Determinants of Antibiotic use | Dr. Jeroen Schouten |
| 11:30 – 13:00 | Workshop “How to assess barriers and facilitators related to optimal antibiotic use” | |
Workshop Implementation in practice (part IV) How to devise an intervention? | ||
14:00 – 16:00 | Workshop “How do I get from a barrier to a | Dr. Milou Fredrix (online) |
16:00 – 18:00 | Group work | |
20:00 | Fire-side chat | to be announced |
DAY 5 | ||
MORNING PROGRAM Special Patient Groups | ||
9:00 –9:30 | AMS in the immuno-compromised patient | Dr. Anke Bruns |
9:30 – 10:00 | AMS in the Emergency department | Dr. Teske Schoffelen |
10:00 – 10:30 | Pediatric AMS | Dr. Gerdien Tramper |
Break | ||
11.00 -12.00 | EXAM | |
“Grande Finale” of the group projects | ||
13:00 – 15:30 | Plenary presentation of team projects to the complete group of experts & discussion | |
15:30 – 16:15 | Closing remarks and certificate ceremony | |
Preliminary programme
Day 1 MORNING PROGRAM Antimicrobial Stewardship Introduction / General principals of antimicrobial therapy | |
09:00 – 09:15 | Welcome and introduction |
09:15 – 10:00 | BASIC requirements of an antimicrobial stewardship Program, an interactive overview |
10:00 – 10:30 | BASIC requirements of an antimicrobial stewardship Program, the role of Microbiology (diagnostic stewardship) |
10:30 – 11:00 | The WHAT of antimicrobial stewardship (objectives) |
Break | |
11:15 – 11:45 | Epidemiology of resistance. Current situation and trends in Europe. How do you weigh this? Where do you get the (local) data from? How does this affect outcomes? |
11:45 – 12:30 | Interdisciplinary consultations: a lesson in empathy / combining multiple perspectives |
AFTERNOON Workshop Implementation in practice (part I) “What is exactly my problem?” | |
13:30 – 14:30 | The HOW of antimicrobial stewardship: how do I make sure that what is implemented/performed in daily practice |
14:30 – 15:00 | Presentation of a “My project” performed by a course Alumnus: “How did I approach my own Antimicrobial Stewardship problem and improve? “ |
15:00 – 16:30 | Workshop: introduction of all participants to their main AMS problem: group discussion to define one major problem per group. |
16:30 – 18:00 | Social Event (Bike tour / Walk in the woods) |
DAY 2 MORNING PROGRAM Optimizing Antimicrobial therapy | |
09:00 – 09:45 | EUCAST methodology of breakpoints , clinical breakpoints, ECOFFs and susceptibility |
09:45 – 10:30 | Practical PK/PD: Leads for optimal dosing, also in situations of altered organ function |
Break | |
11:00 – 11:45 | Practical PK/PD: therapeutic drug monitoring (TDM) to optimize efficacy and prevent toxicity |
11:45 – 12:30 | How to manage (suspected) antibiotic allergy and possibilities for stewardship |
AFTERNOON Workshop Implementation in practice (part IIa) “How do I measure the quantity of antimicrobial use?” | |
13:30 – 14:00 | Quantity of antimicrobial use: the basics |
14:00 – 15:00 | Workshop “How to deduct Quantitative Measures from a raw database and how to analyse and present data” |
Break | |
Workshop Implementation in practice (part IIb) “How do I measure the quality of antimicrobial use?” | |
15:30 – 16:00 | Quality Indicators in Antimicrobial Stewardship, the basics |
16:00 – 17:00 | Workshop “How to operationalize Quality indicators for appropriate antimicrobial use” |
17:00 – 17:30 | Performing a Point Prevalence Survey, the basics |
17:30 – 18:30 | Workshop “How to conduct a Point Prevalence Survey, interpret and present results” |
Free evening | |
DAY 3 MORNING PROGRAM Changing therapy: escalation and de-escalation / IV oral switch | |
09:00 – 09:30 | Markers of inflammation and infection: how to interpret (e.g., CRP, PCT, leukocytes)? Can they be used to tailor treatment duration? |
09:30 – 10:00 | (Rapid) microbiological diagnostics: how to interpret? |
10:00 – 10:30 | Benefits of early IV-oral switch: low hanging fruit in Antimicrobial Stewardship Programs |
Break | |
11:00 – 11:45 | Escalation and De-escalation practice: how to do this in daily practice? |
11:45 – 12:30 | Follow-up diagnostics in S. aureus bacteremia consultations |
AFTERNOON Workshop Implementation in practice (part III) “How do I analyse barriers?” | |
13:30 – 14:00 | Determinants of Antibiotic use |
14:00 – 16:00 | Workshop “How to assess barriers and facilitators related to optimal antibiotic use” |
16:00 – 18:00 | Group work 20:00 Fire-side chat “Optimize communication in AMS” |
DAY 4 MORNING PROGRAM Stopping therapy and discharge with therapy at home | |
09:00 – 09:30 | Stopping antibiotics and duration of antibiotic therapy. Guidelines vs practice |
09:30 – 10:00 | (Prolonged) Antibiotic prophylaxis in perioperative and medical settings |
10:00 – 10:30 | IV antimicrobial therapy at home: OPAT, drug options, controls and toxicity |
Break Workshop Implementation in practice (part IV) How to devise an intervention? | |
11:00 – 13:00 | Workshop “How do I get from a barrier to a potentially effective intervention” |
14:00 – 22:00 | Social Event: Lunch on the go Visit to RIVM / Microbe Museum Diner in Amsterdam |
DAY 5 MORNING PROGRAM Special Patient Groups | |
09:00 – 09:45 | AMS program in Primary Care |
09:45 – 10:30 | AMS program in Long Term care Facilities and End of Life Care |
Break | |
11:00 – 11:30 | AMS in the immune-compromised patient |
11:30 – 12:00 | AMS in the Emergency department |
12:00 – 12:30 | Pediatric AMS to be announced |
AFTERNOON “Grande Finale” of the group projects | |
13:30 – 15:30
| Plenary presentation of team projects to the complete group of experts & discussion |
15:30 – 16:15 | Closing remarks and certificate ceremony |
CMI WEBSITE
EUCAST
